LisaMarieKearnsMDFACP
Internal Medicine • Marysville, OHAssistant Professor-Clinical, The Ohio State University
Dr. Kearns is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
660 London Ave
Suite 1A
Marysville, OH 43040Phone+1 937-642-1550Fax+1 614-688-6471
Education & Training
University of ChicagoClinical Medical Ethics, 2011 - 2012- University of ChicagoMA, Health Services Research , 2010 - 2012
Summa Health System/NEOMEDResidency, Internal Medicine, 2006 - 2009
St Elizabeth Youngstown Hospital/NEOMEDResidency, Surgery, 2006 - 2006
Northeast Ohio Medical UniversityClass of 2006
Certifications & Licensure
MD State Medical License 2022 - 2026
OH State Medical License 2006 - 2026
DC State Medical License 2012 - 2014
IL State Medical License 2010 - 2014- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 34 citationsInternal Medicine Residency Program Director Burnout and Program Director Turnover: Results of a National Survey.Alec B. O'Connor, Andrew J. Halvorsen, John M. Cmar, Kathleen M. Finn, Kathlyn E. Fletcher
The American Journal of Medicine. 2019-02-01 - 17 citationsWhat's the Purpose of Rounds? A Qualitative Study Examining the Perceptions of Faculty and Students.Oliver Hulland, Jeanne M. Farnan, Raphael Rabinowitz, Lisa Kearns, Michele Long
Journal of Hospital Medicine. 2017-09-20 - 4 citationsUsing Telemedicine to Preserve Internal Medicine Residency Continuity Clinic During the COVID-19 Pandemic: Results from a National Survey.Lisa Kearns, Denise Dupras, Jordan Ortiz, Jillian Catalanotti
Journal of General Internal Medicine. 2022-07-01
Press Mentions
Add Covid-Related Myocarditis, Mechanical Ventilation, and Death to This Year’s Football RisksNovember 26th, 2020- Drug Companies Shouldn’t Play Favorites in Granting Access to Experimental Covid-19 TreatmentsOctober 24th, 2020
- Statement of Support for the FDASeptember 11th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
